Plasmodium falciparum MSP6 is a merozoite surface antigen that shows organization and sequence homologies similar to those of MSP3. Within its C-terminus conserved region, it presents some epitopes that are cross-reactive with MSP3 and others that are not, both being targets of naturally occurring antibodies that block the P. falciparum erythrocytic cycle in cooperation with monocytes.Plasmodium falciparum MSP6 has been described recently as a merozoite surface molecule, structurally related in its overall sequence organization to the previously described MSP3 (10, 17). The C-terminal part of the protein shows homology with MSP3 (ca. 50% identity and 85% similarity of amino acid residues) and an identity for an 11-amino-acid (aa) stretch (ILGWEFGGG[A/V]P) previously identified as a target of antibodies with strong antiparasite activity (9, 13). Moreover, the C-terminal part of MSP6 is highly conserved in MSP6, as in the case of MSP3, whereas the N-terminal part displays polymorphisms, is proteolytically cleaved, and is less antigenic than the C-terminal part (10, 18).MSP3 has been identified as a target of protective antibodies by assays involving antibody-dependent cellular inhibition (ADCI), a mechanism found to best reflect the protection that can be passively transferred by antibodies in P. falciparuminfected patients (9). MSP3 has been pursued for human vaccine trials based on the following series of findings suggesting that anti-MSP3 antibodies contribute to protection against malaria. (i) Immunoepidemiological studies showed a significant correlation of immunoglobulin G3 (IgG3) antibodies with protection acquired by natural exposure to the parasite (13,14).(ii) Either naturally occurring or artificially raised antibodies have a strong monocyte-dependent ADCI effect (9, 13). (iii) Immunity can be actively elicited in primates against a P. falciparum challenge and correlates with prechallenge anti-MSP3 antibody titers (7). (iv) Immunity can be passively transferred by anti-MSP3 antibodies in P. falciparum-infected SCID mice (1, 13) and Plasmodium reichnowi-infected chimpanzees (M. Dziegel et al., submitted for publication).Given the homologies of MSP6 with MSP3, we therefore performed a detailed study of the antigenicity of MSP6 and assessed the antiparasite role of the naturally occurring anti-MSP6 antibodies.Antigenicity in populations of areas of endemicity. The C-terminal part of MSP6 (aa 161 to 371 in clone 3D7) was cloned and expressed as a recombinant histidine-tagged protein (MSP6-Cterm), as described earlier (16). Six overlapping peptides